Haemonetics' Q2 Earnings and Revenues Top, Stock Up, Margins Expand [Yahoo! Finance]
Haemonetics Corporation (HAE)
Last haemonetics corporation earnings: 2/4 06:00 am
Check Earnings Report
US:NYSE Investor Relations:
phx.corporate-ir.net/phoenix.zhtml?c=72118&p=irol-irhome
Company Research
Source: Yahoo! Finance
The bottom line surpassed the Zacks Consensus Estimate by 2.8%. On a GAAP basis, the EPS was 66 cents compared with 48 cents in the prior-year quarter. Find the latest EPS estimates and surprises on Zacks Earnings Calendar Following the earnings announcement on Nov. 7, shares of HAE increased 1% in Friday's session, finishing at $87.42. Revenues increased 8.6% (up 3.7% on an organic basis) to $345.5 million in the second quarter of fiscal 2025. The top line beat the Zacks Consensus Estimate by 0.7%. At Plasma , revenues of $138.6 million (accounting for 40.1% of the total revenues) were down 3% year over year (same on an organic basis) in the reported quarter. Our model projected the unit's revenues to be $135.4 million. The decrease resulted from lower sales volumes in North America is related to the previously announced customer transition of CSL Plasma, whose non-exclusive supply agreement with the company is scheduled to expire in December 2025. Revenues at Blood Cen
Show less
Read more
Impact Snapshot
Event Time:
HAE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HAE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HAE alerts
High impacting Haemonetics Corporation news events
Weekly update
A roundup of the hottest topics
HAE
News
- HAE or SYK: Which Is the Better Value Stock Right Now? [Yahoo! Finance]Yahoo! Finance
- Are Investors Undervaluing Haemonetics (HAE) Right Now? [Yahoo! Finance]Yahoo! Finance
- Haemonetics Co. (NYSE: HAE) is now covered by analysts at JPMorgan Chase & Co.. They set an "overweight" rating and a $116.00 price target on the stock.MarketBeat
- Wall Street Analysts See a 27.84% Upside in Haemonetics (HAE): Can the Stock Really Move This High? [Yahoo! Finance]Yahoo! Finance
- Haemonetics Co. (NYSE: HAE) had its "outperform" rating re-affirmed by analysts at Barrington Research. They now have a $108.00 price target on the stock.MarketBeat
HAE
Earnings
- 11/8/24 - Beat
HAE
Sec Filings
- 12/3/24 - Form 8-K
- 11/14/24 - Form SC
- 11/12/24 - Form SC
- HAE's page on the SEC website